BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30694858)

  • 1. Cellular Immunotherapy for Multiple Myeloma.
    Rosenblatt J; Avigan D
    Cancer J; 2019; 25(1):38-44. PubMed ID: 30694858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in immunotherapy in multiple myeloma.
    Boussi L; Niesvizky R
    Curr Opin Oncol; 2017 Nov; 29(6):460-466. PubMed ID: 28877078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-mediated and cellular immunotherapy in multiple myeloma.
    Ritchie DS; Quach H; Fielding K; Neeson P
    Immunotherapy; 2010 Mar; 2(2):243-55. PubMed ID: 20635931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for the treatment of multiple myeloma.
    Boussi LS; Avigan ZM; Rosenblatt J
    Front Immunol; 2022; 13():1027385. PubMed ID: 36389674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune therapy in multiple myeloma.
    Luptakova K; Avigan D
    Clin Adv Hematol Oncol; 2015 Nov; 13(11):767-75. PubMed ID: 27058703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
    Podar K; Jager D
    Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.
    Lee SJ; Borrello I
    Cancer Treat Res; 2016; 169():207-225. PubMed ID: 27696265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment options of T cell-associated immunotherapy in multiple myeloma.
    Liu H; Pan Y; Meng S; Zhang W; Zhou F
    Clin Exp Med; 2017 Nov; 17(4):431-439. PubMed ID: 28120217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immunotherapy as a therapeutic approach in multiple myeloma.
    Liegel J; Avigan D; Rosenblatt J
    Expert Rev Hematol; 2018 Jul; 11(7):525-536. PubMed ID: 29856648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune Therapy.
    Krishnan A; Vij R; Keller J; Dhakal B; Hari P
    Am Soc Clin Oncol Educ Book; 2016; 35():210-21. PubMed ID: 27249701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-based immunotherapy for multiple myeloma.
    Danylesko I; Beider K; Shimoni A; Nagler A
    Immunotherapy; 2012 Sep; 4(9):919-38. PubMed ID: 23046236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Myeloma. Advances in disease biology: therapeutic implications.
    Anderson KC
    Semin Hematol; 2001 Apr; 38(2 Suppl 3):6-10. PubMed ID: 11309702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of multiple myeloma: the start of a long and tortuous journey.
    Harrison SJ; Cook G; Nibbs RJ; Prince HM
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1769-85. PubMed ID: 17181491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for the treatment of multiple myeloma.
    Jung SH; Lee HJ; Vo MC; Kim HJ; Lee JJ
    Crit Rev Oncol Hematol; 2017 Mar; 111():87-93. PubMed ID: 28259300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunotherapy in multiple myeloma.
    Vo MC; Lakshmi TJ; Jung SH; Cho D; Park HS; Chu TH; Lee HJ; Kim HJ; Kim SK; Lee JJ
    Korean J Intern Med; 2019 Sep; 34(5):954-965. PubMed ID: 30754964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma.
    Lendvai N; Cohen AD; Cho HJ
    Bone Marrow Transplant; 2015 Jun; 50(6):770-80. PubMed ID: 25751647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Immunotherapeutic Agents for the Treatment of Multiple Myeloma.
    Rafei H; Haroun F; Tabbara IA
    Am J Clin Oncol; 2019 Mar; 42(3):317-329. PubMed ID: 30557165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodeficiency and immunotherapy in multiple myeloma.
    Pratt G; Goodyear O; Moss P
    Br J Haematol; 2007 Sep; 138(5):563-79. PubMed ID: 17686051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current role of immunotherapy in multiple myeloma.
    Hájek R; Adam Z; Krivanová A; Doubek M; Korístek Z; Vorlícek J
    Acta Med Austriaca; 1998; 25(3):79-85. PubMed ID: 9816399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.